Sorrento, Lee's Pharmaceutical deal

Sorrento granted Lee's Pharmaceutical exclusive rights to develop and commercialize Sorrento's STI-A1014 in Taiwan and China, including Hong Kong and Macau. Sorrento will receive an undisclosed upfron...